Literature DB >> 25128013

Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction.

Jonathan D Cicci1, Larry Buie2, Jill Bates2, Hank van Deventer3.   

Abstract

Entities:  

Keywords:  Denosumab; Hypercalcemia; Multiple myeloma; RANK ligand inhibitor; Renal dysfunction

Mesh：

Substances：

Year:  2014        PMID： 25128013     DOI： 10.1016/j.clml.2014.07.005

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  11 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

Review 2.  [Metabolic disorders as paraneoplastic syndromes].

Authors:  S Krug; P Michl
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

3.  Successful treatment with denosumab for two cases with hypercalcemia due to vitamin D intoxication and associated acute kidney injury.

Authors:  Katharina Barth; Michal Sedivy; Gregor Lindner; Christoph Schwarz
Journal:  CEN Case Rep       Date:  2021-09-13

Review 4.  Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.

Authors:  Paolo Menè; Antonella Stoppacciaro; Silvia Lai; Francescaromana Festuccia
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-05-13

Review 5.  Denosumab: a new agent in the management of hypercalcemia of malignancy.

Authors:  Sonali Thosani; Mimi I Hu
Journal:  Future Oncol       Date:  2015-09-25       Impact factor: 3.404

6.  A case of fatal osteolytic hypercalcemia complicated with IgG4-related ophthalmic disease leading to renal failure.

Authors:  Chieko Kawakita; Masaru Kinomura; Yoshie Gon; Chika Okita; Katsuyoshi Katayama; Mana Nishikawa; Noriaki Shimada; Kenji Notohara; Masaki Fukushima; Kenichiro Asano
Journal:  CEN Case Rep       Date:  2018-08-14

Review 7.  Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

Authors:  Aibek E Mirrakhimov
Journal:  N Am J Med Sci       Date:  2015-11

Review 8.  Hypercalcemia of malignancy and new treatment options.

Authors:  Hillel Sternlicht; Ilya G Glezerman
Journal:  Ther Clin Risk Manag       Date:  2015-12-04       Impact factor: 2.423

9.  Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review.

Authors:  Christina F Marlow; Shailendra Sharma; Faizan Babar; Jianqing Lin
Journal:  Case Rep Oncol Med       Date:  2018-10-14

10.  Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.

Authors:  Jia Song; Fengjuan Jiang; Hui Liu; Kai Ding; Yue Ren; Lijuan Li; Guojin Wang; Zonghong Shao; Rong Fu
Journal:  J Clin Lab Anal       Date:  2019-10-30       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.